Skip to main content
BioNumerik Pharmaceuticals, Inc. Home Page

Science & Technology

BioNumerik Pharmaceuticals, Inc. Feature

Intellectual Property

We are continuing to pursue and progress additional intellectual property protection with respect to Tavocept, Karenitecin and other compounds, technologies, and development areas.